NEUPRO 6 mg/24 h, medicated transdermal patch 30 patches in individual sachets
Active ingredients: (6S)-rotigotine
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch30 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEUPRO 6 mg/24 h, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 30 sachet(s)-dose(s) copolymère d'éthylène aluminium polyéthylène basse densité (PEBD) papier polyéthylène de 1 dispositif(s)
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Jan 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60200500CIP73772134CIP133400937721349Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROTIGOTINEdispositif | 13,5 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.